Ruben A Smith
Impact in
- Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research
- Physiology top 0.2%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 84
- Physiology 75
- Alzheimer's disease research and treatments 65
- Co-authors
- Oskar Hansson (101 shared papers)Sebastian Palmqvist (53 shared papers)Niklas Mattsson-Carlgren (56 shared papers)Erik Stomrud (50 shared papers)Olof T. Strandberg (63 shared papers)Rik Ossenkoppele (50 shared papers)Shorena Janelidze (23 shared papers)Kaj Blennow (17 shared papers)
- Journals
- Alzheimer s & Dementia (43 papers)Brain (13 papers)JAMA Neurology (12 papers)Nature Communications (9 papers)Maternal and Child Health Journal (7 papers)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
Ruben A Smith
181 papers receiving 12.5k citations
Ruben A Smith's Hit Papers
Peers
Comparison fields: 5 of 144
- Psychiatry and Mental health 4.9k
- Physiology 5.1k
- Neurology 1.3k
- Neurology 1.4k
- Biological Psychiatry 200
Countries citing papers authored by Ruben A Smith
This map shows the geographic impact of Ruben A Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruben A Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruben A Smith more than expected).
Fields of papers citing papers by Ruben A Smith
This network shows the impact of papers produced by Ruben A Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruben A Smith. The network helps show where Ruben A Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruben A Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders Hit paper breakdown → | 2020 | 1077 |
| 2 | Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Hit paper breakdown → | 2020 | 948 |
| 3 | Four distinct trajectories of tau deposition identified in Alzheimer’s disease Hit paper breakdown → | 2021 | 521 |
| 4 | The Pregnancy Risk Assessment Monitoring System (PRAMS): Overview of Design and Methodology Hit paper breakdown → | 2018 | 425 |
| 5 | Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease Hit paper breakdown → | 2021 | 418 |
| 6 | Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease Hit paper breakdown → | 2020 | 378 |
| 7 | Discriminative Accuracy of [ 18 F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders Hit paper breakdown → | 2018 | 361 |
| 8 | Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease Hit paper breakdown → | 2020 | 353 |
| 9 | Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline Hit paper breakdown → | 2022 | 328 |
| 10 | 2015 | 301 | |
| 11 | Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease Hit paper breakdown → | 2020 | 291 |
| 12 | Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease Hit paper breakdown → | 2020 | 277 |
| 13 | Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease Hit paper breakdown → | 2020 | 258 |
| 14 | 2019 | 242 | |
| 15 | Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease Hit paper breakdown → | 2021 | 240 |
| 16 | Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care Hit paper breakdown → | 2024 | 227 |
| 17 | 2004 | 222 | |
| 18 | 2021 | 187 | |
| 19 | 2020 | 168 | |
| 20 | 2020 | 166 |
About Ruben A Smith
Ruben A Smith is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Cognitive Neuroscience and Neurology, having authored 195 papers that have together received 12.8k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (84 papers), Alzheimer's disease research and treatments (65 papers), Functional Brain Connectivity Studies (22 papers), Parkinson's Disease Mechanisms and Treatments (16 papers), Medical Imaging Techniques and Applications (13 papers), Neurological disorders and treatments (12 papers), Genetic Neurodegenerative Diseases (10 papers) and Neurological Disease Mechanisms and Treatments (9 papers). The work is most often cited by research in Psychiatry and Mental health (4.9k citations), Physiology (5.1k citations), Neurology (1.3k citations), Neurology (1.4k citations) and Biological Psychiatry (200 citations). Ruben A Smith has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Oskar Hansson, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Erik Stomrud, Olof T. Strandberg, Rik Ossenkoppele, Shorena Janelidze, Kaj Blennow, Henrik Zetterberg and Tomas G. Ohlsson. Their work appears in journals such as Alzheimer s & Dementia, Brain, JAMA Neurology, Nature Communications and Maternal and Child Health Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.